Progress in stem cell-derived technologies for hepatocellular carcinoma

Por Aravalli, Rajagopal N
Publicado em 2010

Role of innate immunity in the development of hepatocellular carcinoma

Por Aravalli, Rajagopal N
Publicado em 2013

Development of MicroRNA Therapeutics for Hepatocellular Carcinoma

Por Aravalli, Rajagopal N.
Publicado no Diagnostics (Basel) (2013)

Immune-Mediated Therapies for Liver Cancer

Por Aravalli, Rajagopal N., Steer, Clifford J.
Publicado no Genes (Basel) (2017)

Relevance of Rabbit VX2 Tumor Model for Studies on Human Hepatocellular Carcinoma: A MicroRNA-Based Study

Por Aravalli, Rajagopal N., Cressman, Erik N. K.
Publicado no J Clin Med (2015)

Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia

Por Aravalli, Rajagopal N, Hu, Shuxian, Lokensgard, James R
Publicado em 2007

Inhibition of Toll-like receptor signaling in primary murine microglia

Por Aravalli, Rajagopal N., Hu, Shuxian, Lokensgard, James R.
Publicado em 2007

Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing

Por Aravalli, Rajagopal N, Talbot, Neil C, Steer, Clifford J
Publicado no World J Gastroenterol (2015)

Histoplasma capsulatum yeast phase-specific protein Yps3p induces Toll-like receptor 2 signaling

Por Aravalli, Rajagopal N, Hu, Shuxian, Woods, Jon P, Lokensgard, James R
Publicado em 2008